Eli Lilly & Co. (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. Its products span oncology, diabetes, immunology, neuroscience, and other therapies. The company is one ...

Six months ago, the Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the class – used to treat type 2 diabetes and obesity – after seeing cases of this type of cancer in ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons. Here is everything you need to know about the weight ...

Jabs such as Wegovy and Mounjaro were originally approved just for Type 2 diabetes but are now approved on the NHS for people who are obese and have other health problems as a consequence.

Emma, who was “fed up” with nothing working, did her research and came across Mounjaro. The self-injectable medication is primarily used to treat type 2 diabetes, but more recently ...

But after seeing a friend slim down on the weight loss jab Mounjaro, Alison decided to take it too. After a consultation with a leading pharmacy, she was approved to take the drug, for around £ ...

What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...

Eli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.

Michael ‘Wippa’ Wipfli, who has been open about his weight issues over the years, told his co-host Ryan ‘Fitzy’ Fitzgerald he had been prescribed the drug Mounjaro which rivals Ozempic.

The launch of Mounjaro always raised the risk that it would cannibalise sales of Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing head-to-head with Ozempic in the market, but ...